Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sucampo Pharma Inc (SCMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 485,056
  • Shares Outstanding, K 46,640
  • Annual Sales, $ 230,060 K
  • Annual Income, $ 18,490 K
  • 36-Month Beta 1.38
  • Price/Sales 2.10
  • Price/Cash Flow 4.29
  • Price/Book 12.18

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.45 +11.64%
on 11/02/17
10.85 -2.76%
on 11/01/17
+0.50 (+4.98%)
since 10/24/17
3-Month
9.45 +11.64%
on 11/02/17
13.15 -19.77%
on 09/11/17
-0.65 (-5.80%)
since 08/24/17
52-Week
9.30 +13.44%
on 04/18/17
17.55 -39.89%
on 11/30/16
-5.15 (-32.80%)
since 11/23/16

Most Recent Stories

More News
Lilly Inks Deal to Include Dexcom Products in Diabetes System

Lilly (LLY) enters into a development agreement with DexCom to integrate the latter's continuous glucose monitoring into its Connected Diabetes Ecosystem.

LGND : 133.71 (+0.49%)
SCMP : 10.55 (+1.44%)
LLY : 84.03 (+0.42%)
DXCM : 55.55 (+0.36%)
Catalyst Initiates Phase II Study for Pipeline Drug Firdapse

Catalyst (CPRX) announces the initiation of phase II study to evaluate safety, tolerability and efficacy of its lead pipeline candidate, Firdapse.

LGND : 133.71 (+0.49%)
SCMP : 10.55 (+1.44%)
BMRN : 82.71 (-0.34%)
CPRX : 3.50 (+4.17%)
Valeant Closes Senior Note Offering, Reprices Term Loan

Valeant (VRX) offered new debt and restructured old debt. The company is making efforts to repay its huge level of debt.

CORT : 17.58 (-0.96%)
LGND : 133.71 (+0.49%)
SCMP : 10.55 (+1.44%)
VRX : 16.57 (+0.18%)
Novartis (NVS) Receives EC Nod for Tasigna Label Expansion

Novartis (NVS) oncology portfolio gets a boost with EC's approval for the label expansion of Tasigna for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic...

SCMP : 10.55 (+1.44%)
LLY : 84.03 (+0.42%)
NVS : 85.08 (+0.71%)
GSK : 35.04 (-0.06%)
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare Conference

Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside chat at the 29 Annual Piper Jaffray Healthcare Conference...

SCMP : 10.55 (+1.44%)
Alnylam's RNAi Candidate Gains Breakthrough Therapy Status

Alnylam (ALNY) announced that the FDA has granted Breakthrough Therapy Designation for RNAi therapeutic candidate, patisiran.

LGND : 133.71 (+0.49%)
SCMP : 10.55 (+1.44%)
ALNY : 132.85 (+0.39%)
SNY : 46.10 (+1.61%)
Cancer Prevention Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference

Cancer Prevention Pharmaceuticals (CPP), a clinical stage biotechnology company, today announced it will give a corporate presentation at the Piper Jaffray 29th Annual Healthcare Conference...

SCMP : 10.55 (+1.44%)
Top 10 Stocks Under $20

Today we've highlighted ten stocks that are currently trading for under $20 per share. All of these stocks currently have a Zacks Rank #1 (Strong Buy), and a variety of other factors make these companies...

VLVLY : 19.3600 (+0.78%)
RST : 12.01 (+3.18%)
SCMP : 10.55 (+1.44%)
SONS : 7.82 (+1.82%)
GRPN : 5.72 (+0.70%)
JSCPY : 19.2500 (+0.36%)
WSTL : 4.30 (+1.90%)
SOUHY : 12.8060 (+0.60%)
KNCAY : 19.3400 (+5.63%)
TKAGY : 19.0300 (+0.05%)
Roche Reports Positive Data From Tecentriq Combination Study

Roche (RHHBY) announced encouraging results from IMpower150 study evaluating the efficacy and safety of Tecentriq in combination with chemotherapy (carboplatin and paclitaxel), with or without Avastin....

CORT : 17.58 (-0.96%)
LGND : 133.71 (+0.49%)
SCMP : 10.55 (+1.44%)
RHHBY : 31.6000 (-0.19%)
Galapagos' CF Candidate Shows Potential in Phase II Study

Galapagos' (GLPG) CFTR corrector candidate, GLPG2222, shows potential in a phase II study on CF patients.

SCMP : 10.55 (+1.44%)
VRTX : 146.55 (-0.33%)
ABBV : 94.72 (+0.26%)
GLPG : 92.23 (+0.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Sucampo Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Sucampo is focused on developing prostones...

See More

Key Turning Points

2nd Resistance Point 10.82
1st Resistance Point 10.69
Last Price 10.55
1st Support Level 10.43
2nd Support Level 10.30

See More

52-Week High 17.55
Fibonacci 61.8% 14.40
Fibonacci 50% 13.42
Fibonacci 38.2% 12.45
Last Price 10.55
52-Week Low 9.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart